APP and Alzheimer disease: Histamine and methylhistamine were significantly elevated in APP/PS1 mice, and previous evidence suggested that neurotransmitter systems including neuronal histamine could contribute to the development and maintenance of AD-related cognitive deficits (Zlomuzica et al., 2016).